论文部分内容阅读
我们于1981年底至1982年初对30例流行性出血热(EHF)患者应用免疫疗法,现将临床疗效及实验研究情况报道如下。研究对象和方法EHF患者系本科于1981年11月至1982年1月间收治的病例,按照1981年诊断标准确诊和分型。随机抽样分成免疫治疗组和对照组各30例。两组患者在年龄、性别、临床分型以及入院病日、病期等方面均相似。免疫治疗组应用环磷酰胺200毫克溶于生理盐水20毫升作静注,每日一次;同时并用转移因子每次2毫升肌注,每日二次,五天为一疗程。分别检测患者使用免疫调整剂疗程前后血
We applied immunotherapy to 30 patients with epidemic hemorrhagic fever (EHF) from the end of 1981 to early 1982. The clinical efficacy and experimental studies are reported below. Subjects and Methods EHF patients undergraduate from November 1981 to January 1982 were admitted to the case, in accordance with the diagnostic criteria for the 1981 diagnosis and classification. Randomly divided into immunotherapy group and control group, 30 cases each. The two groups of patients were similar in age, gender, clinical classification and admission date, disease duration and other aspects. Immunotherapy group with cyclophosphamide 200 mg dissolved in saline 20 ml for intravenous injection, while using transfer factor 2 ml intramuscular injection, twice daily, five days for a course of treatment. Patients were detected using immunomodulator before and after treatment of blood